Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Atrovent HFA (Ipratropium Bromide HFA) Inhalation Aerosol
Company:  Boehringer Inhelheim Pharmaceuticals
Application No.:  021527
Approval Date: 11/17/2004


Date created: January 232007

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.